Blog Read the latest perspectives from our team of subject matter experts and others Unlocking Value-Based Care: How Pharma & MedTech Companies Can Thrive in a New Age of Private Payers and Population HealthAs the healthcare industry shifts to value-based care, private payers and population health are taking the lead in determining patient care. For pharma and med tech companies, this shift… Continue reading → Read the article Post Topics:Commercialization Diversity & Inclusion Drug Development KOL Engagement Medical Devices Provider Data Research Post Industries:Commercialization Medical Devices Payors Pharmaceutical & Biotechnology Provider Data Research Diversity & InclusionDrug DevelopmentKOL EngagementA New Reflection on Pharma, Research, and Patient CarePharma has long existed in elevated, prestigious academic institutions: ivory towers of reputable and revered centers of excellence famous for disseminating the latest in clinical research and medical breakthroughs.… Continue reading → Read the article Drug DevelopmentKOL EngagementH1 Announces Partnership with Society for Clinical Research SitesThe Society for Clinical Research Sites (SCRS) announced today that H1, a pioneer in creating connected ecosystems where data, people, research, and clinical trial intelligence come together to drive the… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchThe Evolution of H1’s Core ValuesI remember it clearly. Me, Ian – our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values… Continue reading → Read the article Diversity & InclusionDrug DevelopmentEquitable Healthcare Starts with Medical AffairsBecause they serve as the bridge between research and commercial functions of life sciences companies, medical affairs can drive equity in clinical trials by proactively engaging with a diverse set… Continue reading → Read the article KOL EngagementA Case Study on Global KOL EngagementIn a recent issue of Nature that traced the origins of key opinion leaders in pharma back to a Pfizer launch in the mid-1950s, the article tracked the evolution and… Continue reading → Read the article KOL EngagementReuters Pharma and MAPS 2022 Event Wrap-UpEvents are back in person and there’s a buzz in the air. Stacey Rivkin, H1’s VP of Client Strategy & Solutions just got back from the 2022 Medical Affairs… Continue reading → Read the article‹1234567›»